Chronic Epstein-Barr virus reactivation after renal transplantation: immunosuppression with cyclosporine versus azathioprine.
Hillebrand
G
G
Nephrology Department, University Hospital Munich-Grosshadern, FRG.
Castro
L A
LA
Schleibner
S
S
Land
W
W
Gurland
H J
HJ
D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D002102:Cadaver; D002213:Capsid / Q000276:immunology; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis*; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D012189:Retrospective Studies
D003524:Cyclosporins; D007074:Immunoglobulin G; D001379:Azathioprine; D008775:Methylprednisolone